Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: A systematic review and meta-analysis

Molecular Human Reproduction

Volumn 19, Issue 3, 2013, Pages 136-143

  Zhao, Linlu ^a,b   Bracken, Michael B ^a,b   DeWan, Andrew T ^a,b   Chen, Suzan ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c University of Medicine and Health Sciences   (United States)

Author keywords

Fibrinolysis; Genetic association study; Plasminogen activator inhibitor 1; Pregnancy; Single nucleotide polymorphism

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1;

ALLELE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDEL MUTATION; META ANALYSIS; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SYSTEMATIC REVIEW;

ALLELES; FEMALE; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MUTAGENESIS, INSERTIONAL; ODDS RATIO; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS, GENETIC; SEQUENCE DELETION;

SCOPUS;

EID: 84876462155     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gas056     Document Type: Review

References (70)

1. Attia J, Thakkinstian A, Wang Y, Lincz L, Parsons M, Sturm J, McGettigan P, Scott R, Meldrum C, Levi C. The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J Stroke Cerebrovasc Dis 2007;16:173-179.
2. Bagos PG. Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol Hum Reprod 2009;15:19-26.
3. Berg CJ, Mackay AP, Qin C, Callaghan WM. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol 2009; 113:1075-1081.
4. Bonnar J, McNicol GP, Douglas AS. Coagulation and fibrinolytic systems in pre-eclampsia and eclampsia. Br Med J 1971;2:12-16.
5. Brouwer MC, Read RC, van de Beek D. Host genetics and outcome in meningococcal disease: a systematic review and meta-analysis. Lancet Infect Dis 2010;10:262-274.
6. Caughey AB, Stotland NE,Washington AE, Escobar GJ. Maternal ethnicity, paternal ethnicity, and parental ethnic discordance: predictors of preeclampsia. Obstet Gynecol 2005;106:156-161.
7. Chen H, Zhao G, Sun M,Wang H, Liu J, Gao W, Meng T. Endothelial nitric oxide synthase gene polymorphisms (G894T, 4b/a and T-786C) and preeclampsia: meta-analysis of 18 case-control studies. DNA Cell Biol 2012;31:1136-1145.
8. Colhoun HM, McKeigue PM, Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003; 361:865-872.
9. Collen D. The plasminogen (fibrinolytic) system. Thromb Haemost 1999; 82:259-270.
10. Dalmaz CA, Santos KG, Botton MR, Tedoldi CL, Roisenberg I. Relationship between polymorphisms in thrombophilic genes and preeclampsia in a Brazilian population. Blood Cells Mol Dis 2006; 37:107-110.
11. Database of Single Nucleotide Polymorphisms (dbSNP). 2012. Reference SNP (refSNP) Cluster Report: rs1799889 [build 137]. Available at: http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=1799889 (5 September 2012, date last accessed).
12. Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359-1375.
13. D'Elia AV, Fabbro D, Driul L, Barillari G, Marchesoni D, Damante G. Plasminogen activator inhibitor-1 gene polymorphisms in pre-eclampsia. Semin Thromb Hemost 2011;37:97-105.
14. De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, Helmerhorst FM, Wladimiroff JW, Bertina RM, De Groot CJ. Preeclampsia and its interaction with common variants in thrombophilia genes. J Thromb Haemost 2004;2:1588-1593.
15. Drenos F, Whittaker JC, Humphries SE. The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann Hum Genet 2007;71:611-619.
16. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogenactivator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851-1855.
17. Estelles A, Gilabert J, Keeton M, Eguchi Y, Aznar J, Grancha S, Espana F, Loskutoff DJ, Schleef RR. Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and/or intrauterine fetal growth retardation. Blood 1994;84:143-150.
18. Estelles A, Gilabert J, Grancha S, Yamamoto K, Thinnes T, Espana F, Aznar J, Loskutoff DJ. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost 1998;79:500-508.
19. Fabbro D, D'Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. Gynecol Obstet Invest 2003;56:17-22.
20. Gao M, Nakabayashi M, Sakura M, Takeda Y. The imbalance of plasminogen activators and inhibitor in preeclampsia. J Obstet Gynaecol Res 1996;22:9-16.
21. Gene. 2012. SERPINE1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 [Homo sapiens]. Available at: http://www.ncbi.nlm.nih.gov/gene/5054 (2 September 2012, date last accessed).
22. Gerhardt A, Goecke TW, Beckmann MW, Wagner KJ, Tutschek B, Willers R, Bender HG, Scharf RE, Zotz RB. The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G/5G genotype are associated with early onset of severe preeclampsia. J Thromb Haemost 2005;3:686-691.
23. Glueck CJ, Phillips H, Cameron D, Wang P, Fontaine RN, Moore SK, Sieve-Smith L, Tracy T. The 4G/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: an independent risk factor for serious pregnancy complications. Metabolism 2000;49:845-852.
24. Glueck CJ, Kupferminc MJ, Fontaine RN, Wang P, Weksler BB, Eldor A. Genetic hypofibrinolysis in complicated pregnancies. Obstet Gynecol 2001;97:44-48.
25. Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls. Thromb Haemost 2009;102:360-370.
26. Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH. Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: a meta-analysis. Thromb Res 2012;130:e43-e51.
27. Hakli T, Romppanen EL, Hiltunen M, Helisalmi S, Punnonen K, Heinonen S. Plasminogen activator inhibitor-1 polymorphism in women with pre-eclampsia. Genet Test 2003;7:265-268.
28. Higgins JPT, Green S. 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. Available at: http://www.medicine.uottawa.ca/public-health-genomics/web/eng/index.html (2 September 2012, date last accessed).
29. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557-560.
30. Ivanov P, Komsa-Penkova R, Ivanov I, Bozhinova S, Stoianova A. Carriers of thrombophilic factor among women with preeclampsia (preliminary report). Akush Ginekol (Sofiia) 2007;46:3-8.
31. Juni P, Holenstein F, Sterne J, Bartlett C, Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int J Epidemiol 2002;31:115-123.
32. Kamal M, El-Khayat W. Do serum angiopoietin-1, angiopoietin-2, and their receptor Tie-2 and 4G/5G variant of PAI-1 gene have a role in the pathogenesis of preeclampsia? J Investig Med 2011;59:1147-1150.
33. Kupferminc MJ. Thrombophilia and pregnancy. Reprod Biol Endocrinol 2003; 1:111.
34. Li YY. Plasminogen activator inhibitor-1 4G/5G gene polymorphism and coronary artery disease in the Chinese Han population: a meta-analysis. PLoS One 2012;7:e33511.
35. Lin R, Lei Y, Yuan Z, Ju H, Li D. Angiotensinogen gene M235T and T174M polymorphisms and susceptibility of pre-eclampsia: a meta-analysis. Ann Hum Genet 2012;76:377-386.
36. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J et al. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009;125:131-151.
37. Loskutoff DJ, Curriden SA. The fibrinolytic system of the vessel wall and its role in the control of thrombosis. Ann NY Acad Sci 1990;598:238-247.
38. Marjot T, Yadav S, Hasan N, Bentley P, Sharma P. Genes associated with adult cerebral venous thrombosis. Stroke 2011;42:913-918.
39. Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Br Med J 2009;339:b2535.
40. Morrison ER, Miedzybrodzka ZH, Campbell DM, Haites NE, Wilson BJ, Watson MS, Greaves M, Vickers MA. Prothrombotic genotypes are not associated with pre-eclampsia and gestational hypertension: results from a large population-based study and systematic review. Thromb Haemost 2002;87:779-785.
41. Mozgovaia EV, Malysheva OV, Ivashchenko TE, Baranov VS. Genetic predisposition to pre-eclampsia: polymorphism of genes involved in regulation of endothelial functions. Balkan J Med Genet 2002;5:19-26.
42. Muetze S, Eggermann T, Leeners B, Birke C, Kuse S, Ortlepp JR, Rudnik-Schoeneborn S, Zerres K, Rath W. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome. J Thromb Thrombolysis 2009;27:141-145.
43. Mutze S, Rudnik-Schoneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. J Perinat Med 2008;36:38-58.
44. Ni S, Zhang Y, Deng Y, Gong Y, Huang J, Bai Y, Zhou R. AGT M235T polymorphism contributes to risk of preeclampsia: evidence from a meta-analysis. J Renin Angiotensin Aldosterone Syst 2012;13:379-386.
45. Nie W, Li B, Xiu QY. The 2675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis. PLoS One 2012;7:e34385.
46. O'Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003;17:385-396.
47. Peck G, Smeeth L, Whittaker J, Casas JP, Hingorani A, Sharma P. The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS One 2008;3:e3691.
48. Pegoraro RJ, Hira B, Rom L, Moodley J. Plasminogen activator inhibitor type 1 (PAI1) and platelet glycoprotein IIIa (PGIIIa) polymorphisms in Black South Africans with pre-eclampsia. Acta Obstet Gynecol Scand 2003;82:313-317.
49. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, Carrier M, Salomon O, Greer IA. The association of factor V leiden and prothrombin gene mutation and placentamediated pregnancy complications: a systematic review and metaanalysis of prospective cohort studies. PLoS Med 2010;7:e1000292.
50. Rosenthal R. The 'file drawer problem' and tolerance for null results. Psychol Bull 1979;86:638-641.
51. Salanti G, Sanderson S, Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med 2005;7:13-20.
52. Scargle JD. Publication bias: the 'file-drawer' problem in scientific inference. J Sci Explor 2000;14:91-106.
53. Shaik AP, Sultana A, Bammidi VK, Sampathirao K, Jamil K. A meta-analysis of eNOS and ACE gene polymorphisms and risk of pre-eclampsia in women. J Obstet Gynaecol 2011;31:603-607.
54. Sham P, McGuffin P. Chapter 3: linkage and association. In McGuffin P, Owen MJ, Gottesman II (eds). Psychiatric Genetics and Genomics. New York, NY: Oxford University Press, 2004, 55-76.
55. Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005; 365:785-799.
56. Sotiriadis A, Makrigiannakis A, Stefos T, Paraskevaidis E, Kalantaridou SN. Fibrinolytic defects and recurrent miscarriage: a systematic review and meta-analysis. Obstet Gynecol 2007;109:1146-1155.
57. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631-644.
58. Tempfer CB, Jirecek S, Riener EK, Zeisler H, Denschlag D, Hefler L, Husslein PW. Polymorphisms of thrombophilic and vasoactive genes and severe preeclampsia: a pilot study. J Soc Gynecol Investig 2004;11:227-231.
59. Teng YC, Lin QD, Lin JH, Ding CW, Zuo Y. Coagulation and fibrinolysis related cytokine imbalance in preeclampsia: the role of placental trophoblasts. J Perinat Med 2009;37:343-348.
60. Thomas DC,Witte JS. Point: population stratification: a problem for case- control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev 2002;11:505-512.
61. Tsantes AE, Nikolopoulos GK, Bagos PG, Tsiara CG, Kapsimali V, Travlou A, Vaiopoulos G. Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of ischemic stroke: a meta-analysis. Blood Coagul Fibrinolysis 2007;18:497-504.
62. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy- Weinberg equilibrium. Am J Hum Genet 2005;76:887-893.
63. Wiwanitkit V. Correlation between plasminogen activator inhibitor-1 4G/ 5G polymorphism and pre-eclampsia: an appraisal. Arch Gynecol Obstet 2006;273:322-324.
64. Xia XP, Chang WW, Cao YX. Meta-analysis of the methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to pre-eclampsia. Hypertens Res 2012 (in press).
65. Xie C, Yao MZ, Liu JB, Xiong LK. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 2011;56:550-559.
66. Xu X, Li J, Sheng W, Liu L. Meta-analysis of genetic studies from journals published in China of ischemic stroke in the Han Chinese population. Cerebrovasc Dis 2008;26:48-62.
67. Yamada N, Arinami T, Yamakawa-Kobayashi K, Watanabe H, Sohda S, Hamada H, Kubo T, Hamaguchi H. The 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene is associated with severe preeclampsia. J Hum Genet 2000;45:138-141.
68. Zhao L, Bracken MB. Association of CD14-260 (-159) C.T and asthma: a systematic review and meta-analysis. BMC Med Genet 2011;12:93.
69. Zhao L, Dewan AT, Bracken MB. Association of maternal AGTR1 polymorphisms and preeclampsia: a systematic review and meta-analysis. J Matern Fetal Neonatal Med 2012;25:2676-2680.
70. Zhong WG, Wang Y, Zhu H, Zhao X. Meta analysis of angiotensin-converting enzyme I/D polymorphism as a risk factor for preeclampsia in Chinese women. Genet Mol Res 2012;11:2268-2276.